Browse Arkansas Code titles and sections
21 U.S.C. § 1503 to 1505 — Repealed. Pub. L. 100–690, title I, § 1009, Nov. 18, 1988, 102 Stat. 4188, as amended by Pub. L. 105–20, § 2(b), June 27, 1997, 111 Stat. 234
Federal law — U.S. Code and appendices · legal_authorities
### Statutory Notes
Section 1503, Pub. L. 100–690, title I, § 1004, Nov. 18, 1988, 102 Stat. 4184, related to coordination between Office of National Drug Control Policy and executive branch departments and agencies. See [section 1704 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1704&num=0&edition=prelim).
Section 1504, Pub. L. 100–690, title I, § 1005, Nov. 18, 1988, 102 Stat. 4185; Pub. L. 103–322, title IX, § 90203, Sept. 13, 1994, 108 Stat. 1991; Pub. L. 105–20, § 2(b), June 27, 1997, 111 Stat. 234, related to annual development and submission of National Drug Control Strategy by President to Congress. See [section 1705 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1705&num=0&edition=prelim).
Section 1505, Pub. L. 100–690, title I, § 1008, formerly § 1003A, as added Pub. L. 101–510, div. A, title X, § 1011, Nov. 5, 1990, 104 Stat. 1633; renumbered § 1008 and amended Pub. L. 103–322, title IX, § 90204(a), (b), (c)(2), (3), Sept. 13, 1994, 108 Stat. 1993, 1994, established Counter-Drug Technology Assessment Center within Office of National Drug Control Policy.
A prior section 1505, Pub. L. 100–690, title I, § 1008, Nov. 18, 1988, 102 Stat. 4188, provided for an executive reorganization study and report to Congress and the President no later than Jan. 15, 1990, prior to repeal by Pub. L. 103–322, § 90204(c)(1).
#### Effective Date of Repeal
Repeal effective Sept. 30, 1997, see section 1009 of Pub. L. 100–690, as amended, which was formerly classified to [section 1506 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1506&num=0&edition=prelim).
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1503 to 1505
Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: 578f95af6a0e60d84c61d7f3ce27aaa19d5ccdd5b977b38211d8eef65cfea464. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Record provenance
Stable record: federal_law:legal_authorities:record_usc_78d9865ba7cc1328d6245730
Source file: Laws/federal/codes/united-states-code/title-21/section-1503-to-1505-21-u-s-c-1503-to-1505-repealed-pub-l-100690-title-i-1009-nov-18-1988-102--0340e7a009.md
Pages: Not recorded – Not recorded
Passage SHA-256: 9d687d923cfedf1539858d7ffe643f206bcad4082dbe6f7b8a3fc0e72b191987
Source location: Title 21, Chapter 20, § 1503 to 1505; chapter-020-national-drug-control-program.md
Stored source content
### Statutory Notes
Section 1503, Pub. L. 100–690, title I, § 1004, Nov. 18, 1988, 102 Stat. 4184, related to coordination between Office of National Drug Control Policy and executive branch departments and agencies. See [section 1704 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1704&num=0&edition=prelim).
Section 1504, Pub. L. 100–690, title I, § 1005, Nov. 18, 1988, 102 Stat. 4185; Pub. L. 103–322, title IX, § 90203, Sept. 13, 1994, 108 Stat. 1991; Pub. L. 105–20, § 2(b), June 27, 1997, 111 Stat. 234, related to annual development and submission of National Drug Control Strategy by President to Congress. See [section 1705 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1705&num=0&edition=prelim).
Section 1505, Pub. L. 100–690, title I, § 1008, formerly § 1003A, as added Pub. L. 101–510, div. A, title X, § 1011, Nov. 5, 1990, 104 Stat. 1633; renumbered § 1008 and amended Pub. L. 103–322, title IX, § 90204(a), (b), (c)(2), (3), Sept. 13, 1994, 108 Stat. 1993, 1994, established Counter-Drug Technology Assessment Center within Office of National Drug Control Policy.
A prior section 1505, Pub. L. 100–690, title I, § 1008, Nov. 18, 1988, 102 Stat. 4188, provided for an executive reorganization study and report to Congress and the President no later than Jan. 15, 1990, prior to repeal by Pub. L. 103–322, § 90204(c)(1).
#### Effective Date of Repeal
Repeal effective Sept. 30, 1997, see section 1009 of Pub. L. 100–690, as amended, which was formerly classified to [section 1506 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section1506&num=0&edition=prelim).
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Access to information**
(1) **In general** — Upon the request of the Director, the head of any National Drug Control Program agency shall cooperate with and provide to the Director any statistics, studies, reports, and other information prepared or collected by the agency concerning the responsibilities of the agency under the National Drug Control Strategy that relate to—
(A) drug control; or
(B) the manner in which amounts made available to that agency for drug control are being used by that agency.
(2) **Protection of intelligence information**
(A) *In general* — The authorities conferred on the Office and the Director by this chapter shall be exercised in a manner consistent with provisions of the National Security Act of 1947 [[50 U.S.C. 3001](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title50-section3001&num=0&edition=prelim) et seq.]. The Director of National Intelligence shall prescribe such regulations as may be necessary to protect information provided pursuant to this chapter regarding intelligence sources and methods.
(B) *Duties of Director* — The Director of National Intelligence and the Director of the Central Intelligence Agency shall, to the maximum extent practicable in accordance with subparagraph (A), render full assistance and support to the Office and the Director.
(3) **Required reports**
(A) *Secretaries of the Interior and Agriculture* — Not later than July 1 of each year, the Secretaries of Agriculture and the Interior shall jointly submit to the Director and the appropriate congressional committees an assessment of the quantity of illegal drug cultivation and manufacturing in the United States on lands owned or under the jurisdiction of the Federal Government for the preceding year.
(B) *Secretary o
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1704
Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) In general**
(1) **Statement of drug policy priorities** — The Director shall release a statement of drug control policy priorities in the calendar year of a Presidential inauguration following the inauguration, but not later than April 1.
(2) **National Drug Control Strategy submitted by the President** — Not later than the first Monday in February following the year in which the term of the President commences, and every 2 years thereafter, the President shall submit to Congress a National Drug Control Strategy.
**(b) Development of the National Drug Control Strategy**
(1) **Promulgation** — The Director shall promulgate the National Drug Control Strategy, which shall set forth a comprehensive plan to reduce illicit drug use and the consequences of such illicit drug use in the United States by limiting the availability of and reducing the demand for illegal drugs and promoting prevention, early intervention, treatment, and recovery support for individuals with substance use disorders.
(2) **State and local commitment** — The Director shall seek the support and commitment of State, local, and Tribal officials in the formulation and implementation of the National Drug Control Strategy.
(3) **Strategy based on evidence** — The Director shall ensure the National Drug Control Strategy is based on the best available evidence regarding the policies that are most effective in reducing the demand for and supply of illegal drugs.
(4) **Process for development and submission of National Drug Control Strategy** — In developing and effectively implementing the National Drug Control Strategy, the Director—
(A) shall consult with—
(i) the heads of the National Drug Control Program agencies;
(ii) each Coordinator listed in [section 1703 of this title](https:
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 1705
Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.